Works matching IS 14741776 AND DT 2009 AND VI 8 AND IP 2

Results: 22

Mechanisms of drug combinations: interaction and network perspectives.

Published in:

2009

By:

Jia Jia;
Feng Zhu;
Xiaohua Ma;
Cao, Zhiwei W.;
Li, Yixue X.;
Yu Zong Chen;
Jia, Jia;
Zhu, Feng;
Ma, Xiaohua;
Cao, Zhiwei;
Li, Yixue;
Chen, Yu Zong

Publication type:

research

Systemic lupus erythematosus.

Published in:

2009

By:

Wentworth, James;
Davies, Clare

Publication type:

journal article

Knocking down barriers: advances in siRNA delivery.

Published in:

2009

By:

Whitehead, Kathryn A.;
Langer, Robert;
Anderson, Daniel G.

Publication type:

journal article

Chloride channels as drug targets.

Published in:

2009

By:

Verkman, Alan S.;
Galietta, Luis J. V.

Publication type:

journal article

Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease.

Published in:

2009

By:

Fraisl, Peter;
Aragonés, Julián;
Carmeliet, Peter;
Aragonés, Julián

Publication type:

journal article

Lung disease: Antioxidant protection against cigarette smoke.

Published in:

Nature Reviews Drug Discovery, 2009, v. 8, n. 2, p. 110, doi. 10.1038/nrd2811

By:

Kingwell, Katie

Publication type:

Article

Lead discovery: Tailoring nuclear receptor activation.

Published in:

Nature Reviews Drug Discovery, 2009, v. 8, n. 2, p. 107, doi. 10.1038/nrd2807

By:

Kirkpatrick, Peter

Publication type:

Article

Stem cells: Modelling genetic diseases with iPS cells.

Published in:

Nature Reviews Drug Discovery, 2009, v. 8, n. 2, p. 108, doi. 10.1038/nrd2809

By:

Flight, Monica Hoyos

Publication type:

Article

Cancer: Identifying drug–genotype interactions.

Published in:

Nature Reviews Drug Discovery, 2009, v. 8, n. 2, p. 109, doi. 10.1038/nrd2808

By:

Harrison, Charlotte

Publication type:

Article

Cardiovascular disease: Silencing microRNA rescues the heart.

Published in:

Nature Reviews Drug Discovery, 2009, v. 8, n. 2, p. 108, doi. 10.1038/nrd2810

By:

Crunkhorn, Sarah

Publication type:

Article

In Brief.

Published in:: Nature Reviews Drug Discovery, 2009, v. 8, n. 2, p. 110, doi. 10.1038/nrd2812
Publication type:: Article

Patent watch.

Published in:

Nature Reviews Drug Discovery, 2009, v. 8, n. 2, p. 100, doi. 10.1038/nrd2815

By:

Harrison, Charlotte

Publication type:

Article

2008 FDA drug approvals.

Published in:

2009

By:

Hughes, Bethan

Publication type:

journal article

News in brief.

Published in:: Nature Reviews Drug Discovery, 2009, v. 8, n. 2, p. 97, doi. 10.1038/nrd2814
Publication type:: Article

Mark McClellan.

Published in:: 2009
Publication type:: Interview

Financing R&D for neglected diseases.

Published in:

2009

By:

Herrling, Paul L.

Publication type:

Editorial

In this issue.

Published in:: Nature Reviews Drug Discovery, 2009, v. 8, n. 2, p. 89, doi. 10.1038/nrd2817
Publication type:: Article

Plerixafor.

Published in:

2009

By:

DiPersio, John F.;
Uy, Geoffrey L.;
Yasothan, Uma;
Kirkpatrick, Peter

Publication type:

journal article

Systems biology.

Published in:

Nature Reviews Drug Discovery, 2009, v. 8, n. 2, p. 173, doi. 10.1038/nrd2820

By:

Young, Malcolm;
Kitano, Hiroaki

Publication type:

Article

Trial watch: Phase III promise for oral multiple sclerosis therapy.

Published in:: 2009
Publication type:: journal article

Deal watch: Bristol–Myers Squibb and Exelixis collaborate on kinase inhibitors.

Published in:: Nature Reviews Drug Discovery, 2009, v. 8, n. 2, p. 98, doi. 10.1038/nrd2822
Publication type:: Article

Regulatory watch: FDA issues guidance for cardiovascular risk assessment of novel antidiabetic agents.

Published in:: Nature Reviews Drug Discovery, 2009, v. 8, n. 2, p. 99, doi. 10.1038/nrd2823
Publication type:: Article